Medicines: Expensive, Poorly Tested, and Often Useless
Blockbuster drugs are launched by the pharmaceuticals industry to great fanfare — with promises of treating intractable illness and often with a stratospheric price tag. Yet, despite the hype and cost, many of those drugs turn out to be less than useless. How is it that so many drugs that are vetted by the Food and Drug Administration escape real scrutiny? Jerry Avorn, one of the most cited scientists in medicine, discusses the deeply compromised state of drug production and government regulation, in thrall to a for-profit system.
Jerry Avorn, Rethinking Medications: Truth, Power, and the Drugs You Take Simon & Schuster, 2025
Center for Science in the Public Interest
The post Medicines: Expensive, Poorly Tested, and Often Useless appeared first on KPFA.